Relevance of the HPA‐15 (Gov) polymorphism on CD109 in alloimmune thrombocytopenic syndromes

@article{Ertel2005RelevanceOT,
  title={Relevance of the HPA‐15 (Gov) polymorphism on CD109 in alloimmune thrombocytopenic syndromes},
  author={Katharina Ertel and Milad Al-Tawil and S. Santoso and H. Kroll},
  journal={Transfusion},
  year={2005},
  volume={45}
}
BACKGROUND: Alloantibodies against the human platelet (PLT) alloantigen (HPA)‐15 system residing on CD109 can cause fetal and neonatal alloimmune thrombocytopenia (FNAIT), posttransfusion purpura, and PLT transfusion refractoriness. The detection of antibodies against HPA‐15, however, is hampered by the variable low expression and instability of the CD109 molecule during preparation and storage. 
The role of alloantibodies against human platelet antigen‐15 in multiply platelet transfused patients
Human platelet‐specific antigen frequencies in Indonesian population
Platelet immunology, present and future
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 40 REFERENCES
Detection of Gov system antibodies by MAIPA reveals an immunogenicity similar to the HPA‐5 alloantigens
Clinical Aspects and Typing of Platelet Alloantigens
...
1
2
3
4
...